
Men's Health
Latest News
Latest Videos

Podcasts
More News

In this video, part 2 in a 5-part series, Nick Liu, MD, breaks down the formulation behind mitomycin for intravesical solution (Zusduri; formerly UGN-102).

In this video, part 1 in a 5-part series, panelists discuss how mitomycin for intravesical solution (formerly UGN-102, now marketed as Zusduri) fits into the evolving management landscape for recurrent bladder tumors.

The trial is evaluating the efficacy of leflutrozole in improving testicular function and promoting spermatogenesis.

Justin Dubin, MD, touches on the current landscape of men’s health, with a specific focus on the advent of AI.

The study also found racial differences in the time to proceeding with surgical therapy.

A recap of the FDA submissions and regulatory decisions in urology from May 2025.

The single-use test can deliver diagnostic results for chlamydia and gonorrhea in approximately 30 minutes.

“What [we] found was that those men who received a penile implant had a significant reduction in depression and psychological distress," says Mohit Khera, MD, MBA, MPH.

Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.

The freedom from re-intervention rate was 71%.

Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.

Experts discuss urgent priapism management strategies, emphasizing timely intervention and collaboration for optimal patient outcomes.

Corinna Hughes, DNP, sits down with Amy Pearlman, MD, to discuss the evolving recognition of APPs in urology.

A discussion on evolution of surgical education, importance of video training, and the future of patient-centered care in reconstruction.

Discover groundbreaking insights in urology as Larry Lipshultz, MD, shares innovative research and strategies for male fertility challenges.

Kathrins discusses the intricacies of leading a clinical trial and why "negative" trials are important to informing care strategies.

New research reveals GLP-1 receptor agonists may enhance sperm counts in overweight men.

This episodes explores the evolving role of GLP-1 medications in testosterone management and their impact on male sexual health and fertility.

Andrew Sun, MD, joins Pearls & Perspectives to discuss innovative approaches to testosterone therapy for enhanced health outcomes.

Helen Bernie, DO, MPH, joins the show to discuss data from her Indiana University team from the floor at AUA 2025.

A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.

A groundbreaking male contraceptive shows promising safety results, offering a reversible option for couples seeking effective birth control.

Pearls & Perspectives, hosted by Amy Pearlman, MD, is the latest multimedia program from Urology Times.

In February 2025, the FDA recommended a removal of the black box warning related to an increased risk of adverse cardiovascular outcomes for all testosterone products. This recommendation has important implications for urologists and the patients they treat.

The average life expectancy was 80.3 years among men with a total motile sperm count over 120 million, compared with 77.6 years among men with a total motile sperm count ranging from >0 to 5 million.
















